A detailed history of Cipher Capital LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cipher Capital LP holds 6,827 shares of BMY stock, worth $401,905. This represents 0.18% of its overall portfolio holdings.

Number of Shares
6,827
Previous 19,311 64.65%
Holding current value
$401,905
Previous $990,000 62.63%
% of portfolio
0.18%
Previous 0.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $598,982 - $679,129
-12,484 Reduced 64.65%
6,827 $370,000
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $645,511 - $770,272
13,315 Added 222.06%
19,311 $990,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $347,108 - $388,121
5,996 New
5,996 $348,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Cipher Capital LP Portfolio

Follow Cipher Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cipher Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Cipher Capital LP with notifications on news.